# Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation

> **NCT03749057** · PHASE4 · COMPLETED · sponsor: **General Hospital of Shenyang Military Region** · enrollment: 400 (actual)

## Conditions studied

- Cerebral Infarction
- TIA

## Interventions

- **DRUG:** Rivaroxaban

## Key facts

- **NCT ID:** NCT03749057
- **Lead sponsor:** General Hospital of Shenyang Military Region
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-20
- **Primary completion:** 2025-03-30
- **Final completion:** 2025-03-30
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2025-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03749057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03749057, "Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03749057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*